Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Gulati

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2025
Sensitivity Measures in Studies of Cancer Early Detection BiomarkersYibai Zhao, Roman Gulati, Jane Lange, et al.
JAMA Network Open|October 9, 2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End PointsKemal Caglar Gogebakan, Jane Lange, Lukas Owens, et al.
JCO Precision Oncology|May 18, 2026
Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling StudyKemal C Gogebakan, Jane Lange, Roman Gulati, et al.
Journal of the National Cancer Institute|May 8, 2021
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based AnalysisYaw A Nyame, Roman Gulati, Eveline A M Heijnsdijk, et al.
Cancer|July 29, 2014
Expected population impacts of discontinued prostate-specific antigen screeningRoman Gulati, Alex Tsodikov, Ruth Etzioni, et al.
Scientific Reports|November 17, 2023
Quantifying the potential benefits of early detection for pancreatic cancer through a counterfactual simulation modeling analysisJiheum Park, Francesca Lim, Matthew Prest, et al.
Journal of the National Cancer Institute|March 30, 2026
Measuring and defining screening benefit in a new era of cancer early detectionRuth Etzioni, Kemal Gogebakan, Roman Gulati, et al.
International Journal of Cancer|January 21, 2014
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaReka Pataky, Roman Gulati, Ruth Etzioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristicsJing Xia, Bruce J Trock, Roman Gulati, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2025
Sensitivity Measures in Studies of Cancer Early Detection BiomarkersYibai Zhao, Roman Gulati, Jane Lange, et al.
JAMA Network Open|October 9, 2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End PointsKemal Caglar Gogebakan, Jane Lange, Lukas Owens, et al.
JCO Precision Oncology|May 18, 2026
Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling StudyKemal C Gogebakan, Jane Lange, Roman Gulati, et al.
Journal of the National Cancer Institute|May 8, 2021
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based AnalysisYaw A Nyame, Roman Gulati, Eveline A M Heijnsdijk, et al.
Cancer|July 29, 2014
Expected population impacts of discontinued prostate-specific antigen screeningRoman Gulati, Alex Tsodikov, Ruth Etzioni, et al.
Scientific Reports|November 17, 2023
Quantifying the potential benefits of early detection for pancreatic cancer through a counterfactual simulation modeling analysisJiheum Park, Francesca Lim, Matthew Prest, et al.
Journal of the National Cancer Institute|March 30, 2026
Measuring and defining screening benefit in a new era of cancer early detectionRuth Etzioni, Kemal Gogebakan, Roman Gulati, et al.
International Journal of Cancer|January 21, 2014
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaReka Pataky, Roman Gulati, Ruth Etzioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristicsJing Xia, Bruce J Trock, Roman Gulati, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
Pageof 16